Vineet Laboratories Ltd.

33.65

0 (0.1%)stock indicator image for downward trend

VINEETLAB Share Price
As on July 3, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap64 Cr
P/E Ratio-1.83
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open34.25
High34.25
NSE SymbolVINEETLAB
Close33.65
Low33.1
BSE Symbol543298
Previous Years High/Low
1 Year High43.5
3 Year High75.02
5 Year High104.64
1 Year Low24.56
3 Year Low22.37
5 Year Low22.37

Technicals


IndicatorsValueSignal
5-DMA33.54Bullish
10-DMA33.89Bearish
20-DMA34.08Bearish
50-DMA35.52Bearish
100-DMA33.32Bullish
200-DMA34.02Bearish

Historical Performance


1 Year
20.3%
3 Years
-24.1%
5 Years
-51%
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:-16.5
3 Years:-9.5
TTM:22.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a low PE of -1.83, which may indicate undervaluation or subdued growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -9.5%, indicating poor shareholder returns.
  • The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported a negative or negligible EBITDA of ₹-143 million, indicating weak operating profitability.
  • In the previous financial year, the company generated revenue of ₹750 million, indicating a relatively small business scale.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 1199241.6
No. of Shares: 35639 (Approx)
Performance:19.9%
P/L: ₹199241.6
NIFTY Performance: -4.7%
1 day Top Gainers
SymbolChange%
SUMICHEM502.3(14%)
ZENSARTECH516.1(10%)
AEGISVOPAK257.43(10%)
ECLERX1488.8(7%)
KAYNES3333.8(6%)
1 Day Top Losers
SymbolChange%
GVT&D4401.5(-9%)
POWERINDIA31040(-8%)
ENRIN3281.5(-8%)
CGPOWER892.55(-7%)
UNIONBANK163.09(-7%)
THERMAX4607.5(-6%)
APARINDS14174(-6%)
TARIL336.75(-6%)

Top Performing Stocks from the same sector


Beta Drugs Ltd.

43.8%

2090.5

1 Month Performance

Bafna Pharmaceuticals Ltd.

41.8%

216.45

1 Month Performance

Ind-Swift Laboratories Ltd.

36.3%

214.16

1 Month Performance

Amanta Healthcare Ltd.

33.3%

163.09

1 Month Performance

Senores Pharmaceuticals Ltd.

32.2%

1381.9

1 Month Performance

Morepen Laboratories Ltd.

30.1%

59.07

1 Month Performance

Caplin Point Laboratories Ltd.

28.6%

2538.1

1 Month Performance

Panacea Biotec Ltd.

27.1%

551.2

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month